Buscar
Mostrando ítems 1-1 de 1
Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor
(MDPI, 2019)
The development of new systemic agents has led us into a “golden era” of management
of metastatic renal cell carcinoma (RCC). Certainly, the approval of immune-checkpoint inhibitors
and the combination of these with ...